BOLT WILLIAM J 4
4 · ABIOMED INC · Filed Apr 2, 2019
Insider Transaction Report
Form 4
ABIOMED INCABMD
BOLT WILLIAM J
SVP, QA and Regulatory Affairs
Transactions
- Award
Common Stock, $.01 par
2019-03-31+56→ 62,182 total
Holdings
- 2,000
Stock Option (Right to Buy)
Exercise: $66.25From: 2016-05-13Exp: 2025-05-13→ Common Stock (0 underlying) - 3,334
Stock Option (Right to Buy)
Exercise: $99.62From: 2017-05-24Exp: 2026-05-24→ Common Stock (0 underlying) - 3,000
Stock Option (Right to Buy)
Exercise: $134.51From: 2018-05-15Exp: 2027-05-15→ Common Stock (0 underlying) - 3,000
Stock Option (Right to Buy)
Exercise: $381.97From: 2019-05-16Exp: 2028-05-16→ Common Stock (3,000 underlying)
Footnotes (4)
- [F1]Grant to reporting person of this option to buy the number of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
- [F2]These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
- [F3]Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
- [F4]These shares of common stock were acquired by the reporting person through participation in the ABIOMED, Inc. Employee Stock Purchase Plan, qualified under Section 423 of the Internal Revenue Code, and the transaction was exempt under Rule 16b-3(c).